BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 25157214)

  • 21. [Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia].
    Veiga-Ruiz G; Domínguez N; Orozco J; Janda M; Hofmockel R; Alvarez-Gómez JA
    Rev Esp Anestesiol Reanim; 2009; 56(6):349-54. PubMed ID: 19725342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
    Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
    Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recovery of laryngeal nerve function with sugammadex after rocuronium-induced profound neuromuscular block.
    Pavoni V; Gianesello L; Martinelli C; Horton A; Nella A; Gori G; Simonelli M; De Scisciolo G
    J Clin Anesth; 2016 Sep; 33():14-9. PubMed ID: 27555126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study.
    Sorgenfrei IF; Norrild K; Larsen PB; Stensballe J; Ostergaard D; Prins ME; Viby-Mogensen J
    Anesthesiology; 2006 Apr; 104(4):667-74. PubMed ID: 16571960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment.
    Panhuizen IF; Gold SJ; Buerkle C; Snoeck MM; Harper NJ; Kaspers MJ; van den Heuvel MW; Hollmann MW
    Br J Anaesth; 2015 May; 114(5):777-84. PubMed ID: 25829395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
    Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK
    Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of profound rocuronium neuromuscular blockade by sugammadex in anesthetized rhesus monkeys.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
    Anesthesiology; 2006 Apr; 104(4):718-23. PubMed ID: 16571967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flucloxacillin and diclofenac do not cause recurrence of neuromuscular blockade after reversal with sugammadex.
    Kam PJ; Heuvel MW; Grobara P; Zwiers A; Jadoul JL; Clerck Ed; Ramael S; Peeters PA
    Clin Drug Investig; 2012 Mar; 32(3):203-12. PubMed ID: 22201295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†,
    Kaufhold N; Schaller SJ; Stäuble CG; Baumüller E; Ulm K; Blobner M; Fink H
    Br J Anaesth; 2016 Feb; 116(2):233-40. PubMed ID: 26787792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex.
    de Boer HD; van Egmond J; Driessen JJ; Booij LH
    Rev Esp Anestesiol Reanim; 2010 Mar; 57(3):181-4. PubMed ID: 20422852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial.
    Pühringer FK; Rex C; Sielenkämper AW; Claudius C; Larsen PB; Prins ME; Eikermann M; Khuenl-Brady KS
    Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of mild hypothermia on reversal of rocuronium-induced deep neuromuscular block with sugammadex.
    Lee HJ; Kim KS; Jeong JS; Kim KN; Lee BC
    BMC Anesthesiol; 2015 Jan; 15():7. PubMed ID: 25971394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
    de Souza CM; Tardelli MA; Tedesco H; Garcia NN; Caparros MP; Alvarez-Gomez JA; de Oliveira Junior IS
    Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of neuromuscular block with sugammadex: a comparison of the corrugator supercilii and adductor pollicis muscles in a randomized dose-response study.
    Yamamoto S; Yamamoto Y; Kitajima O; Maeda T; Suzuki T
    Acta Anaesthesiol Scand; 2015 Aug; 59(7):892-901. PubMed ID: 25962400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients with liver dysfunction undergoing hepatic surgery.
    Fujita A; Ishibe N; Yoshihara T; Ohashi J; Makino H; Ikeda M; Setoguchi H
    Acta Anaesthesiol Taiwan; 2014 Jun; 52(2):54-8. PubMed ID: 25016508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of profound and "deep" residual rocuronium-induced neuromuscular blockade by sugammadex: a neurophysiological study.
    Pavoni V; Gianesello L; De Scisciolo G; Provvedi E; Horton D; Barbagli R; Conti P; Conti R; Giunta F
    Minerva Anestesiol; 2012 May; 78(5):542-9. PubMed ID: 22298182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of sugammadex in patients with a history of pulmonary disease.
    Amao R; Zornow MH; Cowan RM; Cheng DC; Morte JB; Allard MW
    J Clin Anesth; 2012 Jun; 24(4):289-97. PubMed ID: 22608583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Train-of-four ratio recovery often precedes twitch recovery when neuromuscular block is reversed by sugammadex.
    Staals LM; Driessen JJ; Van Egmond J; De Boer HD; Klimek M; Flockton EA; Snoeck MM
    Acta Anaesthesiol Scand; 2011 Jul; 55(6):700-7. PubMed ID: 21574968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation.
    Pongrácz A; Szatmári S; Nemes R; Fülesdi B; Tassonyi E
    Anesthesiology; 2013 Jul; 119(1):36-42. PubMed ID: 23665915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.